TORONTO, Canada - Ubika Research has issued a research bulletin on Medworxx Solutions Inc. (TSX VENTURE: MWX) in a report, "Significant customer win - opportunity to expand further into British Columbia" (dated January 13, 2010). Medworxx Solutions through its patient flow, learning and compliance products helps to improve patient care efficiency and knowledge management within hospitals and other health care organizations.
Ubika Research believes that Medworxx Solutions' customer acquisition of Fraser Health Authority in British Columbia (BC), one of Canada's largest and fastest growing health authorities can be a good referral to further penetrate the large BC health care market. Medworxx Solutions is rated "Speculative Buy" by Ubika Research, with a 12-month target of C$ 0.30.
Download the free report at http://www.smallcappower.com/microsite/CompanyDetail.aspx?CompanyID=14
About Medworxx Solutions Inc.
Medworxx Solutions Inc. (MWX-TSX-V) provides software for patient flow, compliance and education in the healthcare market. Hospitals across North America use its solutions to communicate, aggregate, and analyze knowledge in order to support decision making and regulatory compliance, reduce costs and improve operational efficiency. Based in Toronto, Canada, its marketing footprint spans nine provinces in Canada and 17 states in the U.S.
About Ubika Research
Ubika offers research, analytics and communications solutions to various areas of the financial services industry. We offer solutions that enhance revenue generation capabilities and provide clear competitive advantages. For more information visit www.ubikaresearch.com
About Smallcappower.com
Smallcappower.com provides a premier platform for small and micro-cap companies to showcase their investment potential and to reach to a wide audience of thousands of investors in a thoughtful, comprehensive and engaging manner.
Disclosure
Except for the historical information presented herein, matters discussed in this document contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.
Ubika Research, a division of Ubika Corporation, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this report. For making specific investment decisions, readers should seek their own advice.
For full disclosure please visit: http://www.smallcappower.com/microsite/research_reports.aspx?CompanyID=14
For additional information contact:
Vishy Karamadam, Managing Directorvishy@ubikacorp.com
